Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
16.82
+0.24 (1.45%)
Sep 17, 2026, 10:09 AM EDT - Market open
Avalo Therapeutics Market Cap
Avalo Therapeutics has a market cap or net worth of $902.06 million as of September 17, 2026. Its market cap has increased by 602.54% in one year.
Market Cap
902.06M
Enterprise Value
502.02M
1-Year Change
602.54%
Ranking
Category
Stock Price
$16.82
ChartMarket Cap Chart
Since November 13, 2015, Avalo Therapeutics's market cap has increased from $34.50M to $902.06M, an increase of 2,514.66%. That is a compound annual growth rate of 35.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 902.06M | 173.93% |
| Dec 31, 2025 | 329.30M | 326.55% |
| Dec 31, 2024 | 77.20M | 957.53% |
| Dec 29, 2023 | 7.30M | -84.60% |
| Dec 30, 2022 | 47.40M | -75.17% |
| Dec 31, 2021 | 190.90M | -3.49% |
| Dec 31, 2020 | 197.80M | -16.79% |
| Dec 31, 2019 | 237.70M | 80.35% |
| Dec 31, 2018 | 131.80M | 58.03% |
| Dec 29, 2017 | 83.40M | 917.07% |
| Dec 30, 2016 | 8.20M | -71.63% |
| Dec 31, 2015 | 28.90M | -16.23% |
| Nov 13, 2015 | 34.50M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Wave Life Sciences | 902.48M |
| Olema Pharmaceuticals | 900.35M |
| Theravance Biopharma | 884.18M |
| Lexicon Pharmaceuticals | 881.01M |
| Geron | 880.19M |
| Ardelyx | 877.14M |
| Immix Biopharma | 873.50M |
| Rigel Pharmaceuticals | 847.13M |